During the past decade, Instituto de Neurociencias San Agustín conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Neurociencias San Agustín" are "Depressive Disorder, Major" (2 trials), "Schizophrenia" (2 trials) and "Borderline Personality Disorder" (1 trials). Many other conditions were trialed in "Instituto de Neurociencias San Agustín" in a lesser frequency.

Most popular intervention types in "Instituto de Neurociencias San Agustín" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "SSRI/SNRI" (2 trials), "BI 1358894" (1 trials), "Esketamine" (1 trials) and "Esketamine 28 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Neurociencias San Agustín" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Neurociencias San Agustín". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto de Neurociencias San Agustín, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Neurociencias San Agustín, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".